Vulnerability in NVIDIA Nemoclaw
CVE-2026-65087
NVIDIA NemoClaw contains a vulnerability where an attacker could cause insufficiently protected credentials . A successful exploit of this vulnerability might lead to information disclosure and data tampering.
Published · last modified .
CVSS v3 metric
CVSS v3 base score 5.6 (Medium). Vector: CVSS:3.1/AV:L/AC:L/PR:L/UI:R/S:U/C:H/I:L/A:N.
EPSS exploit prediction
EPSS: 0.002 (3.7th percentile), scored .
Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 4th percentile — 3.7% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.
EPSS over last 30 days · oldest: 0.001 · newest: 0.002 · change: +0.000
Affected products
- NVIDIA Nemoclaw — versions 0 to 0.0.1, 0.0.1
Weakness classification (CWE)
References
- nvd.nist.gov/vuln/detail/CVE-2026-65087 (US Government Resource)
- www.cve.org/CVERecord (Third Party Advisory)
- github.com/NVIDIA/product-security/tree/main/2026/5872 (Patch)
Frequently asked questions
- What is CVE-2026-65087?
- CVE-2026-65087 is a medium-severity vulnerability in NVIDIA Nemoclaw, classified under Insufficiently Protected Credentials. CVSS score: 5.6/10. Published 2026-08-25.
- How severe is CVE-2026-65087?
- Medium severity. CVSS v3 base score is 5.6 out of 10.